AC
AGN

Aristeia Capital’s Allergan plc AGN Stock Holding History

Aristeia Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-49,752
Closed -$11.9M – 53
2017
Q1 		$11.9M Buy
49,752
+33,750
+211% +$7.86M 0.94% 20
2016
Q4 		$3.36M Sell
16,002
-16,550
-51% -$3.43M 0.38% 34
2016
Q3 		$7.5M Buy
32,552
+26,052
+401% +$6.37M 0.41% 27
2016
Q2 		$1.5M Buy
+6,500
New +$1.5M 0.12% 47

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Aristeia Capital's AGN Position: Q2 2017 in Review

Aristeia Capital sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 49,752 shares — an estimated $11.9M sold.

Aristeia Capital first reported a position in AGN in Q2 2016 and held it in 4 quarters. The position peaked at $11.9M in Q1 2017. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Aristeia Capital reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Aristeia Capital sold 49,752 Allergan plc shares in Q2 2017, an estimated $11.9M.
  • Aristeia Capital first reported a position in Allergan plc in Q2 2016 and held it in 4 quarters.
  • Aristeia Capital's Allergan plc position peaked at $11.9M in Q1 2017.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Aristeia Capital's 13F filing for Q2 2017, filed 14 Aug 2017.